Nezeril (Oxymetazoline)

What Is Nezeril and What Is It Used For?

Nezeril is a nasal decongestant containing oxymetazoline hydrochloride, an alpha-adrenergic agonist that rapidly reduces swelling of the nasal mucosa. It is used for short-term treatment of nasal congestion associated with the common cold, providing relief within minutes.

Oxymetazoline works by stimulating alpha-adrenergic receptors in the blood vessels of the nasal passages. When these receptors are activated, the blood vessels constrict, reducing blood flow to the swollen nasal tissue. This vasoconstriction decreases the swelling (edema) of the nasal mucosa, opening up the nasal airways and making it easier to breathe. The effect typically begins within 5 to 10 minutes after application and can last for up to 12 hours, making oxymetazoline one of the longest-acting topical nasal decongestants available.

As an over-the-counter medication, Nezeril is widely available and does not require a prescription. It is primarily indicated for the symptomatic relief of nasal congestion caused by the common cold (acute viral rhinitis). While the medication provides effective symptom relief, it does not treat the underlying cause of the congestion. The common cold is a self-limiting viral illness, and Nezeril serves as a supportive treatment to improve comfort and breathing while the body fights off the infection.

Oxymetazoline, the active ingredient in Nezeril, is one of the most well-studied topical nasal decongestants worldwide. It belongs to the imidazoline class of sympathomimetic amines and has been used clinically since the 1960s. Internationally, oxymetazoline is available under numerous brand names and is included in the World Health Organization's Model List of Essential Medicines for its role in managing nasal congestion. The medication is also sometimes used off-label for the treatment of epistaxis (nosebleeds) and in certain ophthalmic preparations for redness relief.

How Does Oxymetazoline Work in the Nose?

The nasal passages are lined with a richly vascularized mucosa containing capacitance vessels (venous sinusoids) that can fill with blood, causing the tissue to swell. During a cold, inflammatory mediators such as histamine, bradykinin, and prostaglandins cause these vessels to dilate and become more permeable, leading to mucosal edema and increased mucus production. This is what we experience as a "stuffy" or "blocked" nose.

Oxymetazoline acts as a selective alpha-1 and partial alpha-2 adrenergic receptor agonist. By binding to these receptors on the smooth muscle cells of nasal blood vessels, it triggers vasoconstriction. This reduces blood flow through the dilated capacitance vessels, decreasing tissue edema and opening the nasal airway. The dual alpha-1 and alpha-2 activity of oxymetazoline contributes to its prolonged duration of action compared to other nasal decongestants such as phenylephrine or xylometazoline.

Research published in peer-reviewed pharmacological journals has demonstrated that oxymetazoline also possesses mild anti-inflammatory properties, which may contribute to its clinical effectiveness beyond simple vasoconstriction. Studies have shown that oxymetazoline can inhibit the release of certain inflammatory mediators from mast cells and neutrophils, providing an additional mechanism for reducing nasal mucosal swelling.

What Should You Know Before Taking Nezeril?

Before using Nezeril, you should be aware of contraindications including chronic dry rhinitis, potential drug interactions with antidepressants, and precautions for individuals with cardiovascular disease, high blood pressure, or diabetes. Nezeril should not be used in children under 2 years old.

While Nezeril is an over-the-counter medication with a well-established safety profile when used as directed, certain individuals should exercise caution or avoid its use entirely. Understanding the contraindications, warnings, and precautions helps ensure safe and effective treatment. If you are uncertain about whether Nezeril is appropriate for you, always consult a healthcare provider or pharmacist before use.

Contraindications

Nezeril should not be used if you:

• Are allergic to oxymetazoline hydrochloride or any of the other ingredients in the formulation (including hypromellose, disodium edetate, sodium dihydrogen phosphate dihydrate, disodium phosphate dihydrate, sodium chloride, and purified water)
• Have rhinitis sicca or atrophic rhinitis – chronic inflammation of the nasal passages with very dry nasal mucosa. Using a vasoconstricting nasal decongestant in this condition can worsen the dryness and cause further mucosal damage
• Are under 2 years of age – oxymetazoline nasal preparations are not suitable for infants and very young children due to the risk of systemic adverse effects including central nervous system depression

Warnings and Precautions

Speak with a doctor or pharmacist before using Nezeril if you have any of the following conditions:

• Cardiovascular disease (e.g., angina pectoris, coronary artery disease) – oxymetazoline can cause vasoconstriction beyond the nasal passages and may rarely affect blood pressure or heart rate
• High blood pressure (hypertension) – the sympathomimetic effects of oxymetazoline may elevate blood pressure in susceptible individuals
• Diabetes mellitus – sympathomimetic amines can affect blood glucose regulation
• Pheochromocytoma – a rare adrenal gland tumor that produces excess adrenaline; using sympathomimetic agents can precipitate a hypertensive crisis
• Difficulty urinating or enlarged prostate (benign prostatic hyperplasia) – sympathomimetic agents may worsen urinary retention
• Narrow-angle glaucoma – oxymetazoline may increase intraocular pressure in individuals with this condition
• Hyperthyroidism – increased thyroid hormone levels can amplify the cardiovascular effects of sympathomimetic medications

Pregnancy and Breastfeeding

If you are pregnant, breastfeeding, think you may be pregnant, or are planning to have a baby, consult a healthcare provider before using Nezeril.

Pregnancy: There is insufficient data on the use of oxymetazoline during pregnancy. As a precautionary measure, Nezeril should only be used during pregnancy on the advice of a healthcare provider. While topical nasal administration limits systemic absorption, the potential effects on the developing fetus have not been fully evaluated in controlled clinical studies. Some healthcare authorities recommend saline nasal sprays as a first-line treatment for nasal congestion during pregnancy.

Breastfeeding: It is not known whether oxymetazoline passes into breast milk. Because no studies have been conducted, caution is advised. If you are breastfeeding, discuss the risks and benefits with your healthcare provider before using Nezeril.

Driving and operating machinery: Nezeril has no or negligible effect on the ability to drive or operate machinery when used at recommended doses.

How Does Nezeril Interact with Other Drugs?

Nezeril can interact with tricyclic antidepressants, MAOIs, beta-blockers, and other sympathomimetic agents. The most dangerous interactions involve antidepressants (TCAs and MAOIs), which can cause severe hypertensive crisis when combined with oxymetazoline.

Although Nezeril is applied topically to the nasal mucosa and systemic absorption is generally low, clinically significant drug interactions can still occur, particularly with medications that affect the sympathetic nervous system or blood pressure regulation. It is important to inform your healthcare provider or pharmacist about all medications you are taking, including prescription medicines, over-the-counter drugs, and herbal supplements.

Major Interactions

The following interactions are considered clinically significant and may require avoiding the combination or close medical supervision:

Minor Interactions

The following interactions are less severe but should still be considered:

It is particularly important to note that the interaction risk with tricyclic antidepressants and MAOIs extends to a period of up to two weeks after these medications have been discontinued. If you have taken any antidepressant medication within the past two weeks, consult your doctor or pharmacist before using Nezeril.

What Is the Correct Dosage of Nezeril?

Nezeril dosage depends on age: children aged 2-7 years receive 2 drops (0.25 mg/ml) in each nostril 2-3 times daily, children aged 7-10 years receive one single-dose container (0.25 mg/ml) per nostril, and adults and children from 10 years use one single-dose container (0.5 mg/ml) per nostril 2-3 times daily. Maximum duration is 10 days.

Always use Nezeril exactly as described in the patient information leaflet or as directed by your healthcare provider or pharmacist. If you are unsure, consult a healthcare professional before use. The correct dosage varies by age and formulation strength.

Children (2-7 years)

Children (7-10 years)

Adults and Children from 10 Years

How to Use Nezeril Single-Dose Containers

For children (administered by a parent or caregiver):

1. Detach one single-dose container from the strip. Shake the contents down to the bottom of the container.
2. Hold the container upright and twist off the wing tip to open it.
3. If the prescribed dose is 2 drops, first squeeze out 1 drop that should not be used (priming drop). Repeat with a new container so that two containers are ready for use.
4. Gently clean the child's nose.
5. Lay the child on their back with their head tilted backward, or tilt the child's head back.
6. Empty one container into each nostril.
7. Gently turn the child's head alternately to the right and left a few times to distribute the drops across the nasal mucosa.

For adults and children from 10 years:

1. Blow your nose gently.
2. Detach one single-dose container from the strip. Shake the contents down to the bottom. Hold upright and twist off the wing tip.
3. Tilt your head back and empty the container into one nostril. Repeat with a new container for the other nostril.
4. Sniff lightly a couple of times to distribute the drops across the nasal mucosa.

Missed Dose

If you forget to take a dose of Nezeril, simply take the next dose at the usual time. Do not take a double dose to compensate for a missed dose. Because Nezeril is used on an as-needed basis for symptom relief, missing a dose will not affect the overall course of your cold.

Overdose

If you or a child has taken too much Nezeril, or if a child has accidentally ingested the medication, contact your local poison control center or emergency services immediately for risk assessment and guidance. Symptoms of overdose may include nausea, vomiting, cyanosis (bluish skin discoloration), fever, muscle spasms, palpitations, elevated blood pressure, pulmonary edema, respiratory failure, and central nervous system depression. In children, accidental ingestion can be particularly dangerous due to their lower body weight and may cause drowsiness, hypothermia, bradycardia, and respiratory depression.

What Are the Side Effects of Nezeril?

Nezeril is generally well tolerated when used as directed. Uncommon side effects include sneezing and dryness of the mouth and throat. Rare side effects include restlessness, irritability, local nasal irritation, and sleep disturbances in children. Prolonged use beyond 10 days can cause rebound nasal congestion.

Like all medicines, Nezeril can cause side effects, although not everybody gets them. Most side effects are mild and resolve on their own. The frequency of side effects is classified according to international conventions based on the proportion of patients who experience them in clinical trials.

When used at recommended doses and for the recommended duration (no more than 10 days), Nezeril has a favorable safety profile. The most clinically significant adverse effect associated with oxymetazoline nasal preparations is rhinitis medicamentosa (rebound congestion), which occurs with prolonged use beyond the recommended duration. This is not a side effect in the traditional sense but rather a consequence of overuse, and it is entirely preventable by following the dosing instructions.

In addition to the side effects listed above, oxymetazoline nasal preparations may very rarely cause systemic sympathomimetic effects, particularly if used excessively or in patients with the pre-existing conditions mentioned in the precautions section. These potential systemic effects include elevated heart rate (tachycardia), palpitations, elevated blood pressure, headache, and dizziness. Such effects are more likely in the elderly, in patients with cardiovascular disease, and when the recommended dosage is exceeded.

Rebound Congestion (Rhinitis Medicamentosa)

The most important adverse effect to be aware of is rebound nasal congestion, which can develop when oxymetazoline or any topical nasal decongestant is used for more than the recommended duration. Rhinitis medicamentosa occurs because the nasal blood vessels become tolerant to the vasoconstricting effect of the medication. When the drug wears off, the vessels dilate more than they would normally, causing even worse congestion than before treatment. This creates a cycle of dependency where the user feels they need the decongestant just to maintain normal nasal breathing.

If you develop rebound congestion, do not abruptly stop the medication on your own. Consult a healthcare provider who can advise on a safe tapering strategy, which may include gradually reducing the frequency of use, switching to a saline nasal spray, or using a short course of intranasal corticosteroids to help restore normal nasal function.

Reporting Side Effects

Reporting suspected adverse reactions after the medication has been approved is important. It allows for continuous monitoring of the benefit-risk balance of the medication. Healthcare professionals and patients are encouraged to report any suspected adverse reactions to their national pharmacovigilance authority.

How Should You Store Nezeril?

Store Nezeril single-dose containers in their sealed inner envelope. Once the envelope is opened, the containers remain stable for 3 months. Keep out of sight and reach of children. Do not use after the expiry date.

Proper storage of Nezeril is important to maintain the effectiveness and safety of the medication. The single-dose container format is preservative-free, which means the solution does not contain antimicrobial preservatives that would protect against bacterial contamination. Following the storage instructions ensures the sterility and potency of the product.

• Keep containers in their inner envelope even after it has been opened, to protect from light and air exposure
• Opened envelope shelf life: Single-dose containers in an opened inner envelope are stable for 3 months
• Store out of sight and reach of children – accidental ingestion by children can be dangerous
• Do not use after the expiry date printed on the carton and inner envelope. The expiry date refers to the last day of the stated month
• Disposal: Do not dispose of medications via wastewater or household waste. Return unused medications to your pharmacy for proper disposal to protect the environment

What Does Nezeril Contain?

Nezeril contains oxymetazoline hydrochloride as the active substance, available in two concentrations: 0.25 mg/ml and 0.5 mg/ml. The single-dose containers are preservative-free and contain only inactive excipients necessary for the solution formulation.

Understanding the composition of your medication helps you identify potential allergens and ensures safe use. The single-dose container format of Nezeril is notable for being preservative-free, making it suitable for patients who may be sensitive to common nasal spray preservatives such as benzalkonium chloride.

Active Substance

The active ingredient is oxymetazoline hydrochloride.

• Nezeril 0.25 mg/ml: Each 1 ml contains 0.25 mg oxymetazoline hydrochloride (children's strength)
• Nezeril 0.5 mg/ml: Each 1 ml contains 0.5 mg oxymetazoline hydrochloride (adult strength)

Inactive Ingredients (Excipients)

The other ingredients are:

• Hypromellose – a viscosity-increasing agent that helps the solution adhere to the nasal mucosa for prolonged contact time
• Disodium edetate – a chelating agent that enhances the stability of the formulation
• Sodium dihydrogen phosphate dihydrate – a buffering agent that maintains the correct pH
• Disodium phosphate dihydrate – a buffering agent that works together with sodium dihydrogen phosphate to maintain pH
• Sodium chloride – used to adjust the tonicity (osmolality) of the solution to match physiological levels
• Purified water – the solvent for the formulation

Packaging

Nezeril nasal drops in single-dose containers are supplied in plastic single-dose units. The containers are packaged in airtight inner envelopes, with 10 single-dose containers per envelope. The standard package size is 20 single-dose containers (2 envelopes of 10).

The preservative-free single-dose container format offers several advantages: each container provides a sterile, individually sealed dose; there is no risk of contamination between uses; and the absence of preservatives (such as benzalkonium chloride, which is found in many multi-dose nasal sprays) reduces the potential for nasal mucosal irritation with repeated use.

Frequently Asked Questions about Nezeril